← Eichor
Study identifier: NCT07617909 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral Stones

Condition: Distal Ureteral Stone · Urolithiasis · Ureteral Calculi  ·  Sponsor: Beni-Suef University

PhasePhase 2
Planned participants120
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

This study will compare L-citrulline and tamsulosin as medical expulsive therapy for adults with single distal ureteral stones. Eligible participants with a single distal ureteral stone measuring 5 to 10 mm will be randomly assigned to receive either oral L-citrulline 750 mg twice daily or oral tamsulosin 0.4 mg once daily. Treatment will continue until documented stone passage or completion of 4 weeks of therapy, whichever occurs first. Participants will be followed weekly for up to 4 weeks. The main outcome is stone expulsion within 4 weeks. The study will also assess time to stone expulsion, pain episodes, analgesic use, need for additional intervention, and adverse events.

This description comes directly from the study's public registry record.

Talk to the study team

Hany F Badawy, MD  ·  +201149525028  ·  Hanyfathy86@gmail.com

Ahmed Gmal, MD  ·  +20 11 18206022  ·  Drhanyfathy86@GMAIL.COM

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Urology- Beni-Suef University HospitalsBanī Suwayf, Beni Suweif Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07617909